Related Experiment Videos
[Post-transfusion thrombopenia treated with gammaglobulins].
Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1986
Summary
Post-transfusion purpura caused thrombocytopenia and bleeding. High-dose intravenous immunoglobulin therapy successfully treated the condition, highlighting its efficacy in managing rare transfusion reactions.
Area of Science:
- Hematology
- Immunology
- Transfusion Medicine
Background:
- Postoperative thrombocytopenia can arise from various causes, including immune-mediated reactions.
- Post-transfusion purpura (PTP) is a rare but serious complication following blood product transfusion.
Observation:
- A patient developed severe thrombocytopenia and a hemorrhagic syndrome on the eighth postoperative day.
- This was suspected to be PTP, with laboratory confirmation of antiplatelet antibodies unrelated to the PLA1 antigen.
Findings:
- High-dose intravenous human gammaglobulins (IVIg) effectively stabilized the hemorrhage and led to complete recovery.
- The identified antiplatelet antibodies were not associated with the common PLA1 antigen system.
Implications:
- Intravenous immunoglobulin therapy is a viable treatment for PTP when standard platelet transfusions are contraindicated.
- Careful identification of the causative agent is crucial before administering platelet transfusions in suspected immune-mediated thrombocytopenia.